Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells
- 30 November 2004
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 16 (11) , 1319-1327
- https://doi.org/10.1016/j.cellsig.2004.04.003
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Blocking Oncogenic Ras Signaling for Cancer TherapyJNCI Journal of the National Cancer Institute, 2001
- Concepts in Ras-directed therapyExpert Opinion on Investigational Drugs, 1999
- Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-KinaseJournal of Biological Chemistry, 1998
- K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase InhibitorsJournal of Biological Chemistry, 1997
- Selective Inhibition of Ras-dependent Cell Growth by Farnesylthiosalisylic AcidJournal of Biological Chemistry, 1995
- Farnesyl Derivatives of Rigid Carboxylic Acids - Inhibitors of ras-Dependent Cell GrowthJournal of Medicinal Chemistry, 1995
- PROTEIN ISOPRENYLATION AND METHYLATION AT CARBOXYL-TERMINAL CYSTEINE RESIDUESAnnual Review of Biochemistry, 1992
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesPublished by Elsevier ,1988
- Prevalence of ras gene mutations in human colorectal cancersNature, 1987